Novartis Pharmaceuticals Global Marketing Manager Salaries in New York
The average Novartis Pharmaceuticals Global Marketing Manager in New York earns an estimated $163,345 annually, which includes an estimated base salary of $135,595 with a $27,750 bonus. Novartis Pharmaceuticals' Global Marketing Manager compensation is $37,176 more than the US average for a Global Marketing Manager. Global Marketing Manager salaries at Novartis Pharmaceuticals in New York can range from $99,500 - $209,000.
In New York, The Marketing Department at Novartis Pharmaceuticals earns $5,107 more on average than the Operations Department.
Last updated 2 years ago.
- $135,595
- avg. base
- $27,750
- avg. bonus
Global Marketing Manager Salaries at Novartis Pharmaceuticals
In New York, Global Marketing Managers earn $397 more than Global Marketing Managers, and $21,611 less than Directors of Marketing.
Compensation at Novartis Pharmaceuticals by Department
In New York, The Marketing Department averages $5,107 more than the Operations Department, and $10,496 less than the HR Department
Global Marketing Manager Compensation by Gender (All Companies)
The average female Global Marketing Manager at companies similar size to Novartis Pharmaceuticals reported making $151,576, while the average male Global Marketing Manager at similar sized companies reported making $152,234.
Global Marketing Manager Compensation by Ethnicity (All Companies)
The average African American/Black Global Marketing Manager at companies similar size to Novartis Pharmaceuticals reported making $182,500, while the average Native American Global Marketing Manager at similar sized companies reported making $119,055.
How Global Marketing Managers at Novartis Pharmaceuticals Rate Their Compensation
The majority of Global Marketing Managers at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Global Marketing Managers at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
